Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

32.28
+1.023.25%
Post-market: 32.500.2250+0.70%19:30 EDT
Volume:1.29M
Turnover:41.54M
Market Cap:2.31B
PE:-5.47
High:32.97
Open:31.42
Low:31.03
Close:31.26
52wk High:56.05
52wk Low:21.15
Shares:71.71M
Float Shares:62.80M
Volume Ratio:0.52
T/O Rate:2.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8984
EPS(LYR):-4.6644
ROE:-91.75%
ROA:-46.76%
PB:5.68
PE(LYR):-6.92

Loading ...

Analysts Offer Insights on Healthcare Companies: Vera Therapeutics (VERA), Crinetics Pharmaceuticals (CRNX) and Revolution Medicines (RVMD)

TIPRANKS
·
Jul 11

Vera Therapeutics Grants Inducement Equity Awards to Eight New Hires, Sets Options at $40.13 Per Share

Reuters
·
Jul 11

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 11

Vera Therapeutics CEO Fordyce Marshall Sells 46,250 Shares for $1.96 Million

Reuters
·
Jul 10

Vera Therapeutics Names Nancy Bowman Chief Regulatory Officer, Replacing William Turner

Reuters
·
Jul 09

Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William Turner

THOMSON REUTERS
·
Jul 09

Vera Therapeutics' Trutakna Pricing Tops Expectations, Wedbush Says

MT Newswires Live
·
Jul 09

Vera Therapeutics (VERA) Receives a Buy from Jefferies

TIPRANKS
·
Jul 08

Remitly Stock And 2 More Growth Picks With Strong Earnings Forecasts

Simply Wall St.
·
Jul 08

Wedbush Raises Price Target on Vera Therapeutics to $43 From $35, Keeps Neutral Rating

MT Newswires Live
·
Jul 08

Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX) and Vera Therapeutics (VERA)

TIPRANKS
·
Jul 08

Vera Therapeutics, Inc : Guggenheim Raises Target Price to $76 from $56

THOMSON REUTERS
·
Jul 08

Maintaining a Buy on Vera: Commercial-Stage Transition and Trutakna Strength Support Unchanged $90 Price Target

TIPRANKS
·
Jul 08

Vera Therapeutics Exec Says Trutakna's Wholesale Acquisition Cost for Four Doses or 28-day Supply is $32,700 - Conf Call

THOMSON REUTERS
·
Jul 08

Vera Therapeutics is Maintained at Buy by B of a Securities

Dow Jones
·
Jul 08

Under the Radar: Vera Stock Jumps as Kidney-disease Drug Approved by FDA

Dow Jones
·
Jul 08

Vera Therapeutics price target raised to $70 from $65 at BofA

TIPRANKS
·
Jul 08

Vera Therapeutics gains FDA nod for TRUTAKNA launch

TIPRANKS
·
Jul 08

Vera Therapeutics' Drug to Reduce Proteinuria Gets FDA Approval

MT Newswires Live
·
Jul 08

US FDA Approves Vera's Kidney Disease Drug

Reuters
·
Jul 08